USCOM (ASX:UCM) Debt-to-Equity : 1.42 (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is USCOM Debt-to-Equity?

USCOM's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$2.27 Mil. USCOM's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.78 Mil. USCOM's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$2.15 Mil. USCOM's debt to equity for the quarter that ended in Dec. 2023 was 1.42.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for USCOM's Debt-to-Equity or its related term are showing as below:

ASX:UCM' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.21 Med: 0.44 Max: 1.42
Current: 1.42

During the past 13 years, the highest Debt-to-Equity Ratio of USCOM was 1.42. The lowest was 0.21. And the median was 0.44.

ASX:UCM's Debt-to-Equity is ranked worse than
91.82% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs ASX:UCM: 1.42

USCOM Debt-to-Equity Historical Data

The historical data trend for USCOM's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

USCOM Debt-to-Equity Chart

USCOM Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

0.47

0.22

0.36

USCOM Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.21	0.22	0.23	0.36	1.42

Competitive Comparison of USCOM's Debt-to-Equity

For the Medical Devices subindustry, USCOM's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

USCOM's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, USCOM's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where USCOM's Debt-to-Equity falls into.

USCOM Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

USCOM's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.263	+	0.829)	/	3.044
	=	0.36

USCOM's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.269	+	0.779)	/	2.151
	=	1.42

USCOM (ASX:UCM) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

USCOM Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of USCOM's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

USCOM (ASX:UCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » USCOM Ltd (ASX:UCM) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 8, 66 Clarence Street, Suite 2, Sydney, NSW, AUS, 2000

Website

https://www.uscom.com.au

USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. It generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology and the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimizing respiratory device performance.

USCOM (ASX:UCM) Headlines

No Headlines